The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares
Breaking |
Results
Search articles by EPIC code
NEWSFLOWPremaitha Health (#NIPT) – “strong momentum has continued into the second half”, confident
2018-10-25 06:46:55
Premaitha Health (#NIPT) – slightly increased fundraising, including Adam Reynolds taking an additional £50k of shares
2018-10-22 06:51:27
Video - Premaitha presents and grilled at UK Investor City Forum
2018-10-20 07:11:54
Four Premaitha (NIPT) bods presented and faced the music at the UK Investor City forum last week. I was hard on them with my questions as were other members of the audience. But I think they coped well and the shares are most certainly a BUY. Enjoy the video and remember that the next forum (featuring Sosandar) is on 3 December. We will start taking bookings next week.
Premaitha Trading Update - BUY
2018-10-14 14:48:50
Tom Winnifrith writes: For the second time Premaitha (NIPT) has served up a trading update for the six months to 30 September and thus having heard the news before it is hardly shocking. FFS do its PR folks think we are stupid or what? Answering my own question, the self important, over-paid, halfwitted knobheads probably do.
Premaitha (#NIPT) says H1 sales up 45%, has made strong start to H2
2018-10-12 06:45:49
Just 5 (FIVE) places left: 16 October me Dom Frisby, Falanx and a long Premaitha slot plus booze & canapes
2018-10-07 12:43:41
There are now just the last 5 ( of 120) places left for the next Wray family organised UK Investor evening seminar in central London. So if you want to book a slot do so now HERE. The event kicks off with drinks and canapes from 5.30 with the first talk just after six. It will be a packed evening.
Premaitha – Bits and bobs mostly good but...
2018-10-07 12:36:08
I am looking forward to grilling Premaitha (NIPT) at the Nigel Wray London seminar on 16 October. There are still a few places going and its free – details HERE. Meanwhile we have three pieces of news this week following that rather disappointing placing at 10p two Friday's ago caused by the a’hole behaviour of the toads at FinnCap. Yes this is Tom Winnifrith writing…
Premaitha Health (#NIPT) – initial expected circa $1m genetic testing services agreement in Taiwan
2018-10-04 06:23:21
Premaitha – fund raise oversubscribed: we suspect stage management but still a buy
2018-10-03 07:51:49
Under promise and over deliver is what PR poltroons tell their AIM clients. So you say you are looking to raise x but know you will raise x and a bit and then call it a massive success even if the placing is only at 66% of the share price a week or so earlier.
Premaitha – results, placing and the sheer uselessness of broker Finncap - wankers
2018-09-30 10:11:30
Tom Winnifrith writes and has also discussed this in bearcast HERE: We ordinary shareholders in Premaitha (NIPT) have suffered for many years and shown enormous loyalty. News released well after the market close of a £2.5 million placing at 10p might thus seem like a kick in the teeth by a management treating us with contempt. I am afraid the story is far worse.
Premaitha settles Illumina dispute – this is great news: Buy at up to 15p – target 25p
2018-09-20 07:10:05
We have only been waiting three years for this and in the end it came as a complete surprise but a very pleasant one at that. At last Premaitha (NIPT) has settled its patent dispute with American bully boy giants Illumina. This bolt from the blue is great news and now means that a rapidly growing and profitable business will be, at last, valued on fundamentals and that will drive a re-rate which appears to be underway already.
Premaitha Health (#NIPT) – legal settlement & licence and supply agreement with Illumina
2018-09-19 06:49:09
Premaitha (#NIPT) new CEO Lynn Rees - looks a heavy hitter
2018-07-03 23:23:46
Premaitha – deal with Coastal Genomics, not the normal RNS but still STRONG BUY, new target price
2018-06-13 02:51:31
We are getting increasingly used to Premaitha (NIPT) announcing more and more large non-UK distribution agreements. And fear not there will be much more on that front in the weeks and months that lie ahead. It will be a hot summer for Premaitha and for we loyal shareholders. But, for now, there is something a bit different.
Premaitha Health (#NIPT) – agreement to develop technologies for clinical DNA sequencing tests
2018-06-10 23:16:30
Premaitha - Indian Deal, a big deal. Strong Buy
2018-06-07 08:00:00
The rehabilitation of Premaitha Health (NIPT) continues. The latest news is from India where there is not even a whiff of a patent challenge from Illumina and where our boys have signed a 3-year agreement with one of the most advanced clinical laboratory groups in the country to provide a bespoke, high quality and scaleable NIPT solution.
Premaitha Health (#NIPT) – “3-year agreement with one of the most advanced clinical laboratory groups in India”
2018-06-04 23:18:57
Premaitha - placing, trading update, all good good good
2018-05-16 00:09:50
Let's declare an interest first. FIML, a company owned via a Trust by dependents of Tom Winnifrith, took part in the placing at 4.5p but was scaled back so topped up with market purchases at 6.9p.
FinnCap - Premaitha at 7p worth 12p
2018-05-15 05:35:56
It is the house broker so not impartial. I think the target for Premaitha (NIPT) is too low and bought more shares this morning in the secondary market. But here is the Finncap take in a 20 page note:
Premaitha Health (#NIPT) – FY revenue doubled to £6.2m, raises £2.5m at 4.5p
2018-05-14 23:45:39
Premaitha Health (#NIPT) – applications from it and others to strike out newer UK patent claim denied
2018-03-25 23:43:34
Premaitha Health – Egypt IONA test agreement further adds to positive operating momentum
2018-02-20 01:20:11
Premaitha Health (NIPT) has announced an exclusive partner agreement to offer the IONA non-invasive prenatal test across Egypt and a first Egyptian customer…
Premaitha Health (#NIPT) – agreement to offer IONA test across Egypt & first Egyptian customer
2018-02-16 00:20:48
Premaitha gets clearance to sell IONA in Brazil - a strong buy
2018-02-06 02:20:15
Premaitha Health (NIPT) has announced that its IONA test has been approved by Brazil's regulatory authority, Agência Nacional de Vigilância Sanitária (ANVISA), for sale as an in vitro diagnostic test.
Premaitha Health (#NIPT) – IONA test approved for sale in Brazil
2018-02-05 00:42:16
Premaitha Health - granted leave to appeal against Illumina court judgment - BUY
2018-01-26 01:31:43
Updating on Premaitha Health (NIPT) earlier in the week we noted an up to £2.1 million loan facility agreement to fund costs related to the ongoing Illumina litigation and that a Form of Order hearing is scheduled to take place early this week. The shares are currently rising towards 5p on the back of a UK High Court grants right to appeal announcement from the company…
Premaitha Health (#NIPT) – UK High Court grants right to appeal against First Instance Judgment re. Illumina litigation
2018-01-24 00:56:54
Premaitha Health – further loan facility to deal with Illumina legal costs
2018-01-23 05:05:36
On last month-announced results for its half year ended 30th September 2017, we noted Premaitha Health (NIPT) currently looking at positive pre-litigation cashflows, but that there remained risk of low cash headroom or even a cash shortfall including if further litigation-related costs are required. There’s now a Secured loan facility agreement with Thermo Fisher announcement.
Premaitha Health (#NIPT) – up to £2.1m secured loan facility to fund litigation costs
2018-01-22 00:45:23
Premaitha Health – interims, it’s far from gloomy
2018-01-06 10:42:01
Results for its half-year ended 30th September 2017 from Premaitha Health (NIPT) contained some bad news – which sees the shares currently at a depressed little more than 5p, but also many more positive aspects…
Premaitha (#NIPT) H1 sales up 87%, committed to achieving underlying breakeven by March
2017-12-29 00:18:07
Premaitha Health (#NIPT) – four new laboratories in Europe added
2017-12-11 00:44:12
Premaitha Health (#NIPT) – four new Middle East laboratories to offer IONA test
2017-11-27 00:57:52
Premaitha - new partner signed in Asia and there will be more
2017-11-24 09:00:35
After the Illumina legal setback for Premaitha (NIPT) we suggested that the cost of that setback was very manageable – a maximum of less than £2 million is what we hear – and that the underlying business is doing very well. That view is reaffirmed by latest news.
Premaitha loses Illumina court challenge - bad news but not a sell, indeed....
2017-11-22 02:10:29
This is not the news we Premaitha (NIPT) shareholders wanted and it is clearly bad news. The question is how bad? The UK High Court has upheld three patent claims made by Illumina against Premaitha.
Premaitha (#NIPT) – further new customers in Middle East & contracts with three additional laboratories in region
2017-10-12 23:37:56
Premaitha Health (#NIPT) – agreement to offer IONA test in South Africa
2017-09-18 23:36:38
Premaitha - Good News from Brazil but it's the High Court that matters
2017-09-05 07:55:14
Premaitha (NIPT) has announced that it has been approved for Brazilian Good Manufacturing Practice for the company's IONA test by Brazil's regulatory authority, the Agência Nacional de Vigilância Sanitária. Jolly good news and it strengthens the story, but it is not the elephant in the room is it?
Premaitha Health (#NIPT) – progressing approval in Brazil, ‘Good Manufacturing Practice’ approved
2017-08-28 23:49:27
Premaitha - new Thermo Fisher loan: sends strong message to Illumina: BUY
2017-07-16 02:44:21
Premaitha Health (NIPT) has announced that it has entered into a further extension of the investment agreement with Thermo Fisher Scientific announced on 14 December 2015 and extended as announced on 23 September 2016. This is good news.
Premaitha Health (#NIPT) – additional loan facility from Thermo Fisher
2017-07-11 23:59:57
Premaitha (#NIPT) announces 2 new major lab hub contracts in SE Asia
2017-07-09 23:40:40
Premaitha - Court action begins this week - BUY
2017-07-07 06:02:01
And so after more than a year of huff and puff and fascist corporate bullying by US giant Illumina, the High Court action with Premaitha (NIPT) starts tomorrow. Premaitha says:
Premaitha (#NIPT) patent case with fascist corporate bullies Illumina goes to High Court this week
2017-07-02 23:31:41
Premaitha (#NIPT) launches new upgraded model of its kit - Sage
2017-06-15 23:53:20
Premaitha - Indian news but what about the cowboys?
2017-06-09 03:40:25
Premaitha (NIPT) has updated investors on its progress in India where it claims now to have representation in 9 of the 15 most populous states with several of the largest nationwide pathology laboratory groups running Yourgene's NIPT workflow in-house.
Premaitha Health (#NIPT) – India progress update, now in 9 of the 15 most populous states
2017-06-04 23:49:34
Premaitha (#NIPT) says its IONA test works on the Thermo Fisher ION S5 platform
2017-05-25 23:50:53
Premaitha - full year trading statement: BUY
2017-05-18 02:08:06
Premaitha (NIPT) has updated on trading in the year to March 31 2017. Of course, what matters is not historic trading but the future, that is to say the patent challenge by US corporate fascist bully-boys Ilumina. However, some numbers do matter...
Premaitha Health (#NIPT) – trading update emphasises international progress, but no mention of the bottom-line
2017-05-15 23:33:46
Premaitha - puts Swiss distributor Genoma into bankruptcy: BUY
2017-05-13 01:43:18
The issue with Genoma was flagged up in the interims pre-Christmas. It owes Premaitha (NIPT) £750,000. That debt looks like a bad debt because the Swiss company has - despite its parent company concluding a fundraise - been having financial issues. So Premaitha has gone to court and had Genoma made bankrupt.
Premaitha - More Good News: BUY
2017-02-28 01:18:46
We have a new share tip out at 2PM today but here is one which has not dazzled yet. We tipped it an an 18p offer, the shares are now 11.75p-12.5p but we hope readers took our advice and averaged down at as low as 7.5p But the stock is now on a roll and is still cheap. You can catch our new hot tip for just £5 HERE but pro tem back to Premaitha (NIPT).
Premaitha Health (#NIPT) – regulatory clearance for completion of acquisition of Taiwan-based Yourgene Bioscience Co.
2017-02-27 00:38:28
Premaitha at 10.6p worth 18p says FinnCap - new research note
2017-02-20 07:41:24
The fragrant Alice Lane, a foxy young brokerette who apparently I once reduced to tears by being so beastly, is this morning disseminating the latest FinnCap note on Premaitha (NIPT) to clients. Since it is bullish I am happy to make it up to Alice by exposing this high quality research to a wider audience, especially since we own more than a few shares. By way of balance i should say that FinnCap is house broker and therefore utterly partial and you can feel free to ignore every word of this report.
Premaitha Health (#NIPT) – updates on “increasing traction” in the Middle East
2017-02-20 00:31:28
Premaitha share issue - not a grovel sort of placement: BUY
2017-02-17 09:16:18
After two pieces of good news in as many days you do not need to be cynic of the year to expect a placing. But this is not a placing as in the company's broker goes and grovels to fund managers. Premaitha (NIPT) was approached and asked it wanted cash and so has taken £1.487 million at 8.75p per share from Harwood Capital
Premaitha (#NIPT) raises £1.4875m at 8.75p from one institution
2017-02-15 00:17:31
Premaitha - some good news from Southern Europe: Buy
2017-02-13 01:21:35
After a longish period of radio silence Premaitha (NIPT) has served up news of a number of new customers through its distribution network in Southern Europe.
Premaitha Health (#NIPT) – IONA test agreement with “a major European diagnostics services group”
2017-02-13 00:35:07
Premaitha Health (#NIPT) – new customers through Southern Europe distribution network
2017-02-07 00:47:30
Premaitha Health (#NIPT) – conditional acquisition of significant NIPT provider in Asia, Yourgene Bioscience Co., Ltd
2016-12-21 00:44:54
Premaitha - good news from out East: Buy
2016-11-24 05:16:26
Premaitha (NIPT) has announced that its Thai distributor. Geneplus, has formally signed an agreement to offer the Company's IONA test in the Center for Medical Genomics (CMG), Ramathibodi Hospital, Mahidol University, partnering with the Thailand Center of Excellence for Life Sciences.
Premaitha Health (#NIPT) – first service laboratory customer in Asia
2016-11-21 00:53:23
The Vexed Moral Question of Share-Buying -2
2016-11-03 01:00:45
Hello Share Keepers. There were interesting responses to my piece which followed Uncle Tom’s thoughts on Premaitha (NIPT). And there’s probably a bit more to say on the wider picture of buying shares in companies which are doing things you may be uneasy about for your own personal, moral reasons.
Free Iona tests on NHS - good news for Premaitha: Buy
2016-11-02 06:06:11
The Government has announced that as of 2018 it will offer free Non Invasive Prenatal Tests (NIPT) for Downs to women deemed to be at high risk - that is those over 38 years old. Right now it costs you £180 to have an NIPT test rather than an invasive one which has a 1% chance of killing your baby.
The Vexed Moral Dimension of Share Shifting and How to Sleep At Night
2016-11-01 01:00:24
Hello Share Collectors. There is a Mel Gibson film being praised at the moment. It tells the story of a soldier in the Second World War who refused to kill, yet still went into battle to save his colleagues.
Premaitha Health (#NIPT) – welcomes decision to make non-invasive prenatal tests available on NHS
2016-10-31 00:55:39
Premaitha - The Guardian reports that the NHS will offer free NIPT tests from 2018: what about morality?
2016-10-30 06:55:19
The Guardian has reported that as of 2018 the NHS will offer free non invasive tests for Downs to all at risk women. This is great news for AIM listed Premaitha (NIPT) which is a leading provider of such tests. For it there is a clear financial gain but there is an ethical element here which as a shareholder but also a recent father causes me some issues.
Premaitha - upbeat AGM Statement: buy
2016-10-30 04:48:27
And now to what has not, to date, been a good share tip. But it will be and at 9p-9.25p you should average down in Premaitha (NIPT) and buy. The AGM statement this week from chairman Adam Reynolds was upbeat.
NHS to offer non invasive Downs' test to pregnant mums, fantastic news for Premaitha (#NIPT) - The Guardian
2016-10-30 03:22:06
Premaitha Health (#NIPT) – AGM update, “hope to announce shortly a number of sizeable commercial agreements”
2016-10-26 23:48:03
Premaitha - FY Results: numbers academic its the statement that counts: Buy
2016-10-09 00:34:13
Premaitha (NIPT) announced late last week its results for the year to March 31 2016. Given the pace of events here these historic numbers do not mean that much but for the record:
Premaitha (#NIPT) FY numbers - look at statement on current growth, very bullish
2016-09-29 23:54:58
Premaitha - new loan facility - this is the start of more good news: Buy
2016-09-27 06:53:56
Apologies for the delay in commenting on this RNS which landed on Friday. We wanted to speak to Adam Reynolds and we have now done so. This is just the start of the good news and ahead of results tomorrow Premaitha (NIPT) shares are a buy.
Illumina faces hostile $30bn bid says Bloomberg - good news for Premaitha (#NIPT)
2016-08-18 16:45:13
Premaitha - God Bless the EU: Buy
2016-07-10 09:36:56
After 44 years of membership, at last one good thing has come out of the EU for Britain. God bless the Evil Empire. Premaitha (NIPT) has provided an update on its legal battles with US bully boys Illumina.
Premaitha (#NIPT) wins small legal points vs Illumina and heroic EU now investigating Illumina. Good old EU
2016-07-03 23:51:19
Premaitha at 8.6p worth 20p says FinnCap in initiation note
2016-06-06 02:10:23
Finncap is joint broker to Premaitha (NIPT) so is clearly biased. We own shed loads of the shares so are we. So feel free to ignore it all but here is FinnCap's pretty detailed initiation of coverage note.
Video: Dragon's Den 3 from UK Investor Show - Premaitha, Asiamet et al
2016-05-17 00:24:33
In the third Dragon's Den session at UK Investor Show the Dragons were myself (Tom Winnifrith) Steve Moore and Brian Kinane. The companies pitching were United Cacao (CHOC), Premaitha (NIPT), ECR Minerals (ECR), Forbidden Technology (FBT) and Asiamet Resources (ARS)
Premaitha - good news on patent dispute, the shares should double
2016-04-22 01:41:08
Although the twit who handles PR for Premaitha (NIPT) has again contrived to confuse the issue with some garbled press releases this morning there is actually some good news. Fire the idiot PR man and investors could get excited as they discover what is really going on.
Round one in Premaitha (#NIPT) vs yankee bastards Illumina - clear win for Premaitha
2016-04-19 23:13:10
Premaitha – does the company need to sack its PR too?
2016-04-18 06:49:24
This is an utter shambles from AIM-listed Premaitha (NIPT). If you are going to go to the trouble and (shareholders’) expense of putting out an RNS to highlight some paid-for ramping research by Hardman, at least get the bloody RNS right! Tom Winnifrith has already had a furious rant that the company’s Broker, finnCap, should be sacked. Is the same true of the PR genii behind today’s abject efforts?
Premaitha - all sorts of fun and games: buy
2016-04-14 01:32:35
The shares of Premaitha (NIPT) have been all over the shop since what was a cracking year end trading statement on Monday. The reason is the cackhanded disposal of Rupert Lywood's remaining 17.9% stake. We thought he was locked in following his last dump on 9 March and a statement signed off by broker Finncap. Weasel words. His shares were placed by Finncap at just 6.5p with directors taking some and solid institutions Helium, Henderson and Hargreave Hale taking the rest. The overhang is now gone but boy has it crushed the shares. Without Lywood's "assistance" since last summer we think the shares would be 20p today. But he is now out of the picture.
Premaitha (#NIPT) stock overhang cleared, directors buy
2016-04-12 23:39:06
Premaitha (#NIPT) very bullish year end trading update
2016-04-10 23:33:44
Premaitha (#NIPT) signs up 10th lab - its second in France
2016-03-28 23:34:06
Premaitha (#NIPT) signs 2 more distribution deals in the Middle East for IONA
2016-03-21 01:11:54
Premaitha - it is all happening - share weakness explained
2016-03-11 02:55:03
Tom Winnifrith was an insider which restricted him from explaining why shares in Premaitha (NIPT) have been weak of late. Now you can see. The company's largest shareholder Rupert Lywood is a total 100% prat
Premaitha (#NIPT) new distribution deal in Russia with Genext
2016-03-09 01:37:39
Premaitha (#NIPT) gets a proper broker (FinnCap) on board - good news
2016-03-07 00:43:04
Premaitha Company chat - those 2 sets of forecasts and more: buy
2016-02-14 02:16:50
The wider market is taking a bath and Premaitha (NIPT) shares are not immune to this now at 14.5p-15p. But there are also a couple of points which are company specific and in that vein we have had a detailed chat with the company on Friday.
Premaitha - good Leads from Leeds, buy
2016-02-04 02:15:53
Premaitha Health (NIPT) has announced a partnering with Leeds Teaching Hospitals NHS Trust - one of the largest in England - to provide a private non-invasive prenatal screening service for pregnant women in the region.
Premaitha (#NIPT) India link up, this could be huge & is outside Illumina patent issues. Great news
2016-02-03 00:12:22
Premaitha (#NIPT) signs new deal with Leeds NHS Trust
2016-02-02 00:47:43
Premaitha contract wins & litigation timetable: buy
2016-01-31 09:37:00
Premaitha Health (NIPT) has announced further international expansion of its customer base and updated on UK litigation timing
Premaitha (#NIPT) - two more contract wins, good news
2016-01-27 01:23:42
Premaitha - good news from the NHS
2016-01-19 08:04:40
Premaitha Health (NIPT) has welcomed the UK National Screening Committee recommendation to routinely offer non-invasive prenatal testing on the NHS to high-risk pregnant women, noting “this is the first time that non-invasive prenatal testing will be routinely available to high risk pregnant women on the NHS and sets a precedent that we expect other countries to follow in the near future” and that“Premaitha is uniquely positioned to bring the benefits of non-invasive prenatal testing to the NHS”
Zak Mir's Great Request Show: Dechra Pharma, Frontera Resources & Premaitha Health
2016-01-17 04:55:05
Today at the request of my small handful of readers I look at shares in Dechra Pharma (DPH), Frontera Resources (FRR) and Premaitha Health (NIPT) setting share price targets for all three stocks.
Premaitha (#NIPT) - NHS to offer non invasive testing to 20% of pregnant mums
2016-01-15 00:15:59
Premaitha - Illumina are pests but the stance is buy
2016-01-09 09:46:26
Premaitha Health (NIPT) has noted an announcement from Illumina, Inc. of patent infringement suits against Premaitha's customer in Poland and Ariosa Diagnostics, a subsidiary of Roche, and their customer, The Doctors Laboratory, in the UK, while reiterating that it “continues to make a robust defence against earlier claims by Illumina and the board is confident that the IONA test does not infringe the patents as claimed in the earlier cases or in relation to today's announcement”
Tom Winnifrith's share tips of the year No 7 - Buy Premaitha at 18.5p - target 30p
2016-01-03 11:31:07
Ok this was one of my less successful share tips of the year for 2015 but this time it really will come good. That will be the prompt for guffaws of laughter from Wildes, who is currently sitting on a sinking lifeboat from the doomed SS LGO Energy. But he who laughs last...
Zak Mir's Great Request Show: Anglo Asian Mining, Fastnet Equity, Premaitha Health
2015-12-22 04:10:17
If you want me to analyse a stock for you just drop me a line at sqmir@hotmail.com - Today I look at shares in Anglo Asian Mining (AAZ), Fastnet Equity (FAST) and Premaitha Health (NIPT) setting share price targets for all three stocks.
Premaitha - interims and more: buy at up to 24p
2015-12-20 01:13:28
Premaitha Health (NIPT) has announced results for its half year ended 30th September 2015, that “we have a good pipeline of prospects and we are confident that we will continue to build our revenues throughout the forthcoming period” and an up to £5 million loan facility from $17 billion revenue science company Thermo Fisher.
Premaitha (#NIPT) - director buys 180k shares - not a trivial vote of confidence
2015-12-18 00:12:08
Premaitha (#NIPT) announces paid for researcher Hardman publishes report - SO WHAT?
2015-12-15 00:21:19
Video: Adam Reynolds How To Invest in Shells presentation at Gold & Bears November 2015
2015-12-14 04:00:23
And now it is the shellmeister Adam Reynolds, he of Optibiotix (OPTI), New World Oil & Gas (NEW) and Premaitha (NIPT) fame presenting at Gold & Bears. A full interview by the Sith Lord with Adam is out today and can be read HERE. Enjoy the video.
Premaitha (#NIPT) gets £5m loan from Thermo Fisher at 6%, TF also gets warrants at 24.2p
2015-12-14 00:17:15
Premaitha - 3 year vote of confidence from France: buy
2015-12-03 07:27:54
Premaitha Health (NIPT) has announced Adgenix as its exclusive distributor in France and that Adgenix has already signed up its first laboratory customer - with a “contract for a minimum of three years to supply LaboSud with the IONA test”
Premaitha (#NIPT) breaks into French market with a three year deal
2015-12-02 00:28:23
Premaitha: stunning test results what we need are contracts, wont be long
2015-11-14 02:26:32
Premaitha (NIPT) has announced some pretty stunning results from an independent test of its IONA test published in the Journal of Ultrasound, Obstetrics in Gynecology. Dam, why did we not get ahead of the news and subscribe to that must read publication? It sounds gripping stuff.
Premaitha Health (#NIPT) - Strengthens board as part of commercialisation strategy
2015-10-28 00:23:02
Zak Mir's Great Request Show: Ferrexpo, Paragon Entertainment & Premaitha Health
2015-10-27 03:27:27
If you want me to analyse a stock for you just drop me a line at sqmir@hotmail.com - Today I look at shares in Ferrexpo (FXPO), Paragon Entertainment (PEL), Premaitha Health (NIPT), and setting share price targets for all three stocks
Premaitha Health (#NIPT) - Clinical laboratory with expanded capacity opened
2015-10-13 23:35:04
Premaitha Health (#NIPT) - Sets up collaboration with Wolfson screening lab
2015-10-12 23:21:56
Premaitha (#NIPT) - Independent study shows incredible accuracy of IONA
2015-10-11 23:35:55
Premaitha - average down - buy
2015-10-11 07:59:02
Premaitha Health (NIPT) has announced an agreement with the leading distributor of scientific products in Greece (Antisel SA) to provide its IONA test to clinical laboratories in the region and that it has been informed that American company Illumina, Inc. has added a third patent to its suit against it. Buy, sell or hold?
Premaitha (#NIPT) - signs new IONA distribution deal in Greece - Cala
2015-10-01 23:06:40
Premaitha (#NIPT) - wins new IONA contract in Chile
2015-09-21 23:38:01
Buy Premaitha Health at a 20p offer, says Tom Winnifrith
2015-09-19 02:01:17
This was not going to be my tip in the recently published book "The Magnificent 7" which you can download for free HERE. I was set to tip Optibiotix (OPTI) at c40p. Unfortunately for you (but fortunately for me since we own shares in the company) the share price has raced ahead to a 48p offer. I still think that they could head much higher and Zak Mir reckons that Optibiotix shares will be 60p by October. I think, that is what a chartist terms a long term view.
Premaitha Health (#NIPT) - CQC accreditation for new NIPT lab
2015-07-05 23:05:54
Premaitha Health (#NIPT) - proposed placing to raise £8million
2015-07-01 23:29:50
Premaitha Health (#NIPT) - New clinical data for Iona test showcased
2015-06-23 23:08:04
Premaitha: Buy at 25p on contract news - target 31p says Panmure Gordon
2015-06-22 04:44:38
Panmure Gordon is house broker to Premaitha (NIPT) so take its morning note with a pinch of salt. It is paid to say buy. However for what it is worth here is its analysis of today's news and its forecasts.
Premaitha (#NIPT) announces new contract for IONA test - good news
2015-06-21 23:17:26
Premaitha - NHS testing IONA - this is potentially enormous
2015-06-08 01:43:08
The Daily Mail & BBC this weekend ran stories about how the NHS was doing trials which would see all pregnant women getting a non invasive pre-natal test for down's syndrome. The Mail piece sums it up HERE
Buy Premaitha at a 26.75p offer - target 35p to sell by September
2015-06-05 03:26:29
We have tipped Premaitha (NIPT) before and our readers have banked big gains on it Now the time is right for re-entry and so this Adam Reynolds biotech play was our second May share tip of the month.
Zak Mir's Great Request Show: JKX Oil & Gas, Premaitha Health, RapidCloud International.
2015-05-24 02:53:00
If you want me to analyse a stock for you just drop me a line at sqmir@hotmail.com - Today I look at JKX Oil & Gas, Premaitha Health and RapidCloud International.
Premaitha (#NIPT) files robust defence & counter claim vs Illumina
2015-05-04 23:42:21
Why I’m sticking with Premaitha – cracking news today, BTW
2015-03-23 07:20:36
Last week was a bit of a stomach churner for Premaitha (NIPT). The shares zoomed for about 30 minutes as it announced a stunning deal to commercialise its IONA test. They the tanked as a US giant launched a patent infringement case. Today they are zooming – up 37% at 24p – but I am not selling. In fact I am just kicking myself for not buying more at 16p a week ago!
Premaitha (#NIPT) Commercialisation begins - first deal signed. Hooray!
2015-03-16 00:20:54
Premaitha – how high could it go in the Long Term? I am asked
2015-02-09 04:27:26
In short: I am buggered if I know. The Nifty Fifty tipped the shares at a 15p offer and out target to sell is 30p as noted HERE at the weekend. The shares are now 24.5p to sell.
Premaitha launches Iona test as it gets CE mark ..shares up but more to come
2015-02-08 04:47:49
A few weeks earlier than we had expected, Premaitha Health (NIPT) has announced that it has received CE-mark approval for its Iona test and will therefore launch it commercially at once. This is good news and the shares are now 23.5p – 24.5p.
Premaitha (#NIPT) gets CE mark and launches Iona - great news
2015-02-05 00:15:39
Premaitha - good news but not quite the sealed deal yet
2015-01-31 09:07:57
Premaitha (NIPT) has announced that it is almost there on getting the crucial CE-mark for its IONA test. It has passed two key milestones including ISO 13485:2003 certification which confirms that Premaitha's quality management system has been approved as applicable to the design, development and manufacture of in vitro diagnostic reagents and associated software for non-invasive assessment of genetic abnormalities.
Premaitha (#NIPT) almost there on CE Mark - prepares for commercial launch: Good news!
2015-01-30 00:19:14
Tom Winnifrith’s sixth share tip of the year 2015, buy Premaitha at a 19.5p offer
2015-01-01 05:11:41
One of the reasons that capitalism works while the alternative is doomed to fail is that failing companies can reinvent themselves.
Premaitha Results and share price - buy at up to 19p ahead of Jan news
2014-12-20 04:34:40
Shares in Premaitha (NIPT) have slipped back to 17-17.5p as part of the pre Christmas non Santa rally. Results for the 7 months to 30 September were largely a Vialogy tidy up and were no great shakes. It is what will happen in 2015 that matters.
Premaitha (#NIPT) - very bullish share tip in the Daily Mail
2014-12-16 01:08:11
Roche buys Ariosa – Panmure’s bullish Read across for Premaitha
2014-12-02 09:39:33
Today Pharma giant Roche has snapped up a California based form Ariosa which is big in what is termed NIPT. Panmure Gordon, house broker to Premaitha (NIPT) reckons this has a clear read across for its AIM listed client. In a note sent out today it writes:
Premaitha - good AGM statement: Buy
2014-11-06 07:36:45
Premaitha Health (NIPT) has updated investors attending its AGM that it believes its lead product “remains on target to be the first regulated CE marked ‘in vitro’ diagnostic product in the rapidly growing market for non-invasive prenatal screening”.
Premaitha (#NIPT) - upbeat AGM statement - on track for commercialisation
2014-11-04 00:04:55
Premaitha at 18.75p – Panmure Initiates coverage with a buy stance and 23p target (detailed note)
2014-10-30 09:22:25
Panmure Gordon, house broker to Premaitha (NIPT) has initiated its coverage of the stock at 18.75p. It rates the shares as a buy with a 23p target, based on applying a 30% discount to a peer group analysis. The note from analyst Mike Mitchell is a detailed 23 page study.
Video of Premaitha presentation at the ShareProphets Seminar
2014-10-09 07:15:51
Heck, I am biased, we own these shares, but I thought that the presentation by Stephen Little and Adam Reynolds of Premaitha (NIPT) at the first ShareProphets seminar was pretty compelling. I certainly view the shares as cheap on the basis of what I heard. To ensure that you get priority booking for future seminars (the next one on 13 October is now booked out but we will start taking bookings for 27 October next week) register HERE.
Premaitha – Share Options award: Reiterate buy stance
2014-10-03 07:13:46
It sticks in the craw when management award themselves share options at 10p when the share price is 17p. But that is what Premaitha (NIPT) announced yesterday. However
Tip of the week update: Premaitha 40% ahead after 2 weeks – to double from here by Christmas
2014-09-20 07:57:32
AIM listed Premaitha (NIPT) was our share tip of the week two weeks ago at 10.75p – the shares are now 15.75p but are still a buy from here – we expect them to double by Christmas.
ShareProphets Tip of the Week: Buy Premaitha at 10.75p
2014-09-07 13:11:57
AIM listed Vialogy (VIY) was a perennial dog. That was all meant to change following the reversal of Premaitha into the business at 11p in July. So far the now renamed Premaitha Group (NIPT) has failed to sparkle. The shares are now 10.75p. But after a summer lull we reckon that is all about to change. Big time and soon. Hence it is our share tip of the week.
Search ShareProphets |
Recent Comments |